annual EBITDA:
-$53.18M-$10.82M(-25.53%)Summary
- As of today (August 22, 2025), PLSE annual EBITDA is -$53.18 million, with the most recent change of -$10.82 million (-25.53%) on December 31, 2024.
- During the last 3 years, PLSE annual EBITDA has risen by +$8.69 million (+14.04%).
- PLSE annual EBITDA is now -1317.84% below its all-time high of -$3.75 million, reached on December 31, 2015.
Performance
PLSE EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly EBITDA:
-$20.01M-$2.25M(-12.65%)Summary
- As of today (August 22, 2025), PLSE quarterly EBITDA is -$20.01 million, with the most recent change of -$2.25 million (-12.65%) on June 30, 2025.
- Over the past year, PLSE quarterly EBITDA has dropped by -$8.55 million (-74.59%).
- PLSE quarterly EBITDA is now -3428.75% below its all-time high of -$567.00 thousand, reached on March 31, 2015.
Performance
PLSE quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM EBITDA:
-$69.23M-$8.55M(-14.09%)Summary
- As of today (August 22, 2025), PLSE TTM EBITDA is -$69.23 million, with the most recent change of -$8.55 million (-14.09%) on June 30, 2025.
- Over the past year, PLSE TTM EBITDA has dropped by -$24.24 million (-53.89%).
- PLSE TTM EBITDA is now -12110.76% below its all-time high of -$567.00 thousand, reached on March 31, 2015.
Performance
PLSE TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
PLSE EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -25.5% | -74.6% | -53.9% |
| 3 y3 years | +14.0% | -46.6% | -15.9% |
| 5 y5 years | -13.7% | -80.5% | -43.9% |
PLSE EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -25.5% | +14.0% | -137.9% | at low | -79.5% | at low |
| 5 y | 5-year | -25.5% | +14.0% | -137.9% | at low | -79.5% | at low |
| alltime | all time | -1317.8% | +14.0% | -3428.8% | at low | <-9999.0% | at low |
PLSE EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Jun 2025 | - | -$20.01M(+12.7%) | -$69.23M(+14.1%) |
| Mar 2025 | - | -$17.76M(-1.8%) | -$60.69M(+14.0%) |
| Dec 2024 | -$53.18M(+25.5%) | -$18.08M(+35.0%) | -$53.24M(+12.3%) |
| Sep 2024 | - | -$13.39M(+16.8%) | -$47.39M(+5.3%) |
| Jun 2024 | - | -$11.46M(+11.1%) | -$44.99M(+3.5%) |
| Mar 2024 | - | -$10.32M(-15.6%) | -$43.46M(+2.5%) |
| Dec 2023 | -$42.37M(-25.3%) | -$12.23M(+11.3%) | -$42.40M(+9.9%) |
| Sep 2023 | - | -$10.99M(+10.7%) | -$38.58M(-14.8%) |
| Jun 2023 | - | -$9.93M(+7.2%) | -$45.28M(-7.6%) |
| Mar 2023 | - | -$9.26M(+10.1%) | -$49.00M(-13.6%) |
| Dec 2022 | -$56.70M(-8.4%) | -$8.41M(-52.5%) | -$56.69M(-10.6%) |
| Sep 2022 | - | -$17.69M(+29.6%) | -$63.39M(+6.2%) |
| Jun 2022 | - | -$13.65M(-19.5%) | -$59.71M(-1.5%) |
| Mar 2022 | - | -$16.95M(+12.1%) | -$60.61M(-2.1%) |
| Dec 2021 | -$61.87M(+26.6%) | -$15.11M(+7.9%) | -$61.90M(+2.7%) |
| Sep 2021 | - | -$14.01M(-3.7%) | -$60.26M(+2.3%) |
| Jun 2021 | - | -$14.54M(-20.3%) | -$58.89M(+6.2%) |
| Mar 2021 | - | -$18.25M(+35.4%) | -$55.44M(+13.4%) |
| Dec 2020 | -$48.87M | -$13.47M(+6.6%) | -$48.88M(-0.4%) |
| Sep 2020 | - | -$12.64M(+14.0%) | -$49.07M(+2.0%) |
| Jun 2020 | - | -$11.09M(-5.1%) | -$48.13M(-0.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2020 | - | -$11.68M(-14.5%) | -$48.42M(+3.4%) |
| Dec 2019 | -$46.79M(+27.7%) | -$13.66M(+16.8%) | -$46.82M(+11.8%) |
| Sep 2019 | - | -$11.70M(+2.8%) | -$41.88M(+2.9%) |
| Jun 2019 | - | -$11.38M(+12.9%) | -$40.70M(+6.4%) |
| Mar 2019 | - | -$10.08M(+15.6%) | -$38.25M(+4.6%) |
| Dec 2018 | -$36.65M(+47.7%) | -$8.72M(-17.0%) | -$36.57M(+0.5%) |
| Sep 2018 | - | -$10.51M(+17.7%) | -$36.38M(+10.0%) |
| Jun 2018 | - | -$8.93M(+6.3%) | -$33.08M(+9.6%) |
| Mar 2018 | - | -$8.40M(-1.4%) | -$30.17M(+21.6%) |
| Dec 2017 | -$24.81M(+181.1%) | -$8.53M(+18.2%) | -$24.81M(+31.0%) |
| Sep 2017 | - | -$7.21M(+19.6%) | -$18.94M(+32.1%) |
| Jun 2017 | - | -$6.03M(+97.9%) | -$14.34M(+38.1%) |
| Mar 2017 | - | -$3.05M(+14.9%) | -$10.38M(+17.6%) |
| Dec 2016 | -$8.83M(+135.3%) | -$2.65M(+1.7%) | -$8.83M(+17.3%) |
| Sep 2016 | - | -$2.61M(+25.9%) | -$7.52M(+26.0%) |
| Jun 2016 | - | -$2.07M(+38.4%) | -$5.97M(+27.6%) |
| Mar 2016 | - | -$1.50M(+11.0%) | -$4.68M(+24.8%) |
| Dec 2015 | -$3.75M | -$1.35M(+27.7%) | -$3.75M(+56.1%) |
| Sep 2015 | - | -$1.06M(+35.4%) | -$2.40M(+78.4%) |
| Jun 2015 | - | -$780.00K(+37.6%) | -$1.35M(+137.6%) |
| Mar 2015 | - | -$567.00K | -$567.00K |
FAQ
- What is Pulse Biosciences, Inc. annual EBITDA?
- What is the all time high annual EBITDA for Pulse Biosciences, Inc.?
- What is Pulse Biosciences, Inc. annual EBITDA year-on-year change?
- What is Pulse Biosciences, Inc. quarterly EBITDA?
- What is the all time high quarterly EBITDA for Pulse Biosciences, Inc.?
- What is Pulse Biosciences, Inc. quarterly EBITDA year-on-year change?
- What is Pulse Biosciences, Inc. TTM EBITDA?
- What is the all time high TTM EBITDA for Pulse Biosciences, Inc.?
- What is Pulse Biosciences, Inc. TTM EBITDA year-on-year change?
What is Pulse Biosciences, Inc. annual EBITDA?
The current annual EBITDA of PLSE is -$53.18M
What is the all time high annual EBITDA for Pulse Biosciences, Inc.?
Pulse Biosciences, Inc. all-time high annual EBITDA is -$3.75M
What is Pulse Biosciences, Inc. annual EBITDA year-on-year change?
Over the past year, PLSE annual EBITDA has changed by -$10.82M (-25.53%)
What is Pulse Biosciences, Inc. quarterly EBITDA?
The current quarterly EBITDA of PLSE is -$20.01M
What is the all time high quarterly EBITDA for Pulse Biosciences, Inc.?
Pulse Biosciences, Inc. all-time high quarterly EBITDA is -$567.00K
What is Pulse Biosciences, Inc. quarterly EBITDA year-on-year change?
Over the past year, PLSE quarterly EBITDA has changed by -$8.55M (-74.59%)
What is Pulse Biosciences, Inc. TTM EBITDA?
The current TTM EBITDA of PLSE is -$69.23M
What is the all time high TTM EBITDA for Pulse Biosciences, Inc.?
Pulse Biosciences, Inc. all-time high TTM EBITDA is -$567.00K
What is Pulse Biosciences, Inc. TTM EBITDA year-on-year change?
Over the past year, PLSE TTM EBITDA has changed by -$24.24M (-53.89%)